Royal Bank Of Canada Sc Pharmaceuticals Inc. Transaction History
Royal Bank Of Canada
- $528 Billion
- Q2 2025
A detailed history of Royal Bank Of Canada transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 503,707 shares of SCPH stock, worth $2.42 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
503,707
Previous 1,946
25784.22%
Holding current value
$2.42 Million
Previous $5,000
38280.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding SCPH
# of Institutions
101Shares Held
37MCall Options Held
757KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA6.06MShares$29.1 Million0.82% of portfolio
-
Rubric Capital Management LP New York, NY4.6MShares$22.1 Million0.4% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.87MShares$18.6 Million8.33% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX3.54MShares$17 Million0.06% of portfolio
-
Morgan Stanley New York, NY2.15MShares$10.3 Million0.0% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $132M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...